Number of shares and votes in Active Biotech
December 30 2016 - 2:36AM
The number of shares and votes in Active Biotech has changed as
a result of the recently completed rights issue.
Today, the last trading day of the month, there are in total
96,824,320 shares and votes in Active Biotech.
For further information, please contact:Tomas
Leanderson, CEO Tel: +46 (0)46 19 20 95E-mail:
tomas.leanderson@activebiotech.com
Hans Kolam, CFOTel: +46 (0)46 19 20 44E-mail:
hans.kolam@activebiotech.com
Active Biotech ABP.O. Box 724,
SE-220 07 Lund, SwedenPhone +46 (0)46 19 20 00
Active Biotech AB (publ)
(Nasdag Stockholm: ACTI) is a biotechnology company with focus on
neurodegenerative/inflammatory diseases and cancer. Laquinimod, an
orally administered small molecule with unique immunomodulatory
properties, is in pivotal Phase 3 development for the treatment of
relapsing remitting multiple sclerosis. Also, laquinimod is in
Phase 2 development for the treatment of primary progressive
multiple sclerosis and Huntington's disease. Furthermore,
commercial activities are conducted for the tasquinimod, paquinimod
and SILC projects. Please visit www.activebiotech.com for more
information.
Active Biotech is required to publish the
information contained in this press release in accordance with the
Financial Instruments Trading Act. This information was provided to
the media for publication at 08.30 am CET on December 30, 2016.
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/c8d7f1ff-19bb-4c24-8286-00ca44067514
Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart
From Apr 2023 to Apr 2024
